Insights into the Molecular Mechanisms of Eg5 Inhibition by (+)-Morelloflavone

Abstract

(+)-Morelloflavone (MF) is an antitumor biflavonoid that is found in the Garcinia species. Recently, we reported MF as a novel inhibitor of ATPase and microtubules-gliding activities of the kinesin spindle protein (Eg5) in vitro. Herein, we provide dynamical insights into the inhibitory mechanisms of MF against Eg5, which involves binding of the inhibitor to the loop5/α2/α3 allosteric pocket. Molecular dynamics simulations were carried out for 100 ns on eight complexes: Eg5-Adenosine diphosphate (Eg5-ADP), Eg5-ADP-S-trityl-l-cysteine (Eg5-ADP-STLC), Eg5-ADP-ispinesib, Eg5-ADP-MF, Eg5-Adenosine triphosphate (Eg5-ATP), Eg5-ATP-STLC, Eg5-ATP-ispinesib, and Eg5-ATP-MF complexes. Structural and energetic analyses were done using Umbrella sampling, Molecular Mechanics Poisson–Boltzmann Surface Area (MM/PBSA) method, GROMACS analysis toolkit, and virtual molecular dynamics (VMD) utilities. The results were compared with those of the known Eg5 inhibitors; ispinesib, and STLC. Our data strongly support a stable Eg5-MF complex, with significantly low binding energy and reduced flexibility of Eg5 in some regions, including loop5 and switch I. Furthermore, the loop5 Trp127 was trapped in a downward position to keep the allosteric pocket of Eg5 in the so-called “closed conformation”, comparable to observations for STLC. Altered structural conformations were also visible within various regions of Eg5, including switch I, switch II, α2/α3 helices, and the tubulin-binding region, indicating that MF might induce modifications in the Eg5 structure to compromise its ATP/ADP binding and conversion process as well as its interaction with microtubules. The described mechanisms are crucial for understanding Eg5 inhibition by MF.

Natural Alkaloid Berberine Activity against Pseudomonas aeruginosa MexXY-Mediated Aminoglycoside Resistance: In Silico and in Vitro Studies

“… a Tobramycin breakpoints: S ≤ 4 μg/mL, I = 8 μg/mL, R ≥ 16 μg/mL b M, mucoid; N, nonmucoid. c Reduction of tobramycin MIC ≥ 2-fold. …”

“…Indeed, the adjustment of the ligand pose inside its binding cleft is quite common in those cases in which the cleft is much larger than the ligands' volume, as is the case of site 2. This adjustment can thus also be associated to the variation of the aminoacids involved in the specific interaction 21,[34][35][36][37] . In MexY, close to site 2 (also reported as DP site) 16 there is an enlargement of the cavity (AP site by Ruggerone et al 2018) 16 considerably larger in MexB and MexY than in AcrB, where it is known as proximal multisite drug-binding pocket; 16,36,37 this suggests the possibility for a ligand to bind in different orientations and/or at different sub-pockets, a hypothesis compatible with the multisite-drugoscillation 36 and diffuse binding 37 in these proteins.…”

Integrated Machine Learning and Chemoinformatics-Based Screening of Mycotic Compounds against Kinesin Spindle ProteinEg5 for Lung Cancer Therapy

“…ATP-competitive inhibitors of Eg5, including the biphenyl derivatives, have been reported to bind with the protein between the α4 and α6 helices. In Eg5, switch I forms repeated contacts with the γ-phosphate of ATP while switch II offered a β-hairpin conformation [ 47 ].…”

Combining Multi-Dimensional Molecular Fingerprints to Predict hERG Cardiotoxicity of Compounds

“…The MD trajectories were analyzed by the GROMACS toolkit (Ogunwa, 2019). Following features has been generated: radius of gyration (rgyr), solvent-accessible surface area (sasa), root mean squared error (rmsd), total energy (tenergy), hydrogen bonds (hbond), kinetic energy (kinetic), Lennard-Jones short-range energies (LJ-SR) and Lennard-Jones 1-4 energies (LJ-14).…”